Tin tức & Cập nhật

Biologic agents raise IBD risk among axSpA patients
Biologic agents raise IBD risk among axSpA patients
08 Feb 2023

Based on observational studies, patients with axial spondyloarthritis (axSpA) treated with biologics are at higher risk of inflammatory bowel disease (IBD), while findings from randomized controlled trials (RCTs) suggest that treatment with etanercept (ETN) tends to increase such risk compared to other antitumour necrosis factor (anti-TNF) therapies, according to the result of a meta-analysis.

Biologic agents raise IBD risk among axSpA patients
08 Feb 2023
Obesity tied to gestational diabetes risk
Obesity tied to gestational diabetes risk
08 Feb 2023

Obesity appears to exert a detrimental causal effect on the risk of gestational diabetes, with lipid metabolism acting as a potential driver of the relationship, according to the results of a Mendelian randomization analysis.

Obesity tied to gestational diabetes risk
08 Feb 2023